Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-Tao Zhan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Cancer Research : MCR|December 27, 2022
IFT20 Confers Paclitaxel Resistance by Triggering β-arrestin-1 to Modulate ASK1 Signaling in Breast CancerNi Qiu, Huan Jin, Lulu Cui, et al.
Archives of Pathology & Laboratory Medicine|April 22, 2026
An Innovative Diagnostic Strategy for Malignant Pleural Effusion Using Discontinuous Gradient CentrifugationJin-Xin Zhu, Lei Yuan, Yong-Tao Zhan, et al.
Cancer Letters|August 29, 2019
Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K/AKT pathwayNi Qiu, Yu-Fang He, Si-Ming Zhang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Cancer Research : MCR|December 27, 2022
IFT20 Confers Paclitaxel Resistance by Triggering β-arrestin-1 to Modulate ASK1 Signaling in Breast CancerNi Qiu, Huan Jin, Lulu Cui, et al.
Archives of Pathology & Laboratory Medicine|April 22, 2026
An Innovative Diagnostic Strategy for Malignant Pleural Effusion Using Discontinuous Gradient CentrifugationJin-Xin Zhu, Lei Yuan, Yong-Tao Zhan, et al.
Cancer Letters|August 29, 2019
Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K/AKT pathwayNi Qiu, Yu-Fang He, Si-Ming Zhang, et al.
Pageof 1